Finzati - Logo
CVS logo

CVS Health Corp.

CVS • Medical - Healthcare Plans
$96.74
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$123.73B
Growth
8.8%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 9.4%Positive free cash flow · 6.16Consistent free cash flow · 5/5Expensive earnings multiple · 56.87Weak liquidity · 0.84
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$96.74
Change0.00%
Shares Out1.28B
Market Cap$123.73B
Enterprise Value$175.04B
52W Range58.50 - 103.12
Beta0.49
P/E42.20
P/S0.30
P/B1.60
P/FCF16.73
EV/Sales0.43

Investment DNA

How strong this company looks for long-term investors

55
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
35/100
Growth Potential
Revenue and expansion
56/100
Price Attractiveness
Cheap or expensive today
69/100
Why this score▼
Positive revenue growth · 9.4%Positive free cash flow · 6.16Consistent free cash flow · 5/5Expensive earnings multiple · 56.87Weak liquidity · 0.84Weak profitability

Analyst view

Analyst sentiment and price target

CVS
Analyst sentiment
Based on 41 analyst votes · 2026-09-05
93/100
Bullish
Bullish
35
Hold
6
Bearish
0
Price Target
2026-06-24
Low
$90.00
Mean
$103.64
Median
$106.00
High
$115.00

Company Overview

IPO: 2/21/1973
Industry: Medical - Healthcare Plans
P/B i: 1.60
Debt / Equity i: 1.24
Operating Margin: 2.58%
Net Margin: 0.44%
ROE i: -
ROIC: -

Financial Health

Score7 / 20
Debt / Equity: 1.24
Current Ratio: 0.84
Quick Ratio: 0.63
Status: Weak

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
Compton-Phillips Amy
Transaction: 05/31/2026
SELL
Change
-7,618
Price
$90.98
Filing
06/01/2026
Type
SELL
Newman Brian
Transaction: 05/31/2026
SELL
Change
-2,478
Price
$90.98
Filing
06/01/2026
Type
SELL
AGUIRRE FERNANDO
Transaction: 05/21/2026
SELL
Change
-1,563
Price
$93.50
Filing
05/22/2026
Type
SELL